Senate Dems’ Bill Uses Exclusivity As Leverage To Keep Rx Prices In Line

By John Wilkerson
February 8, 2019 at 2:10 PM
Five Democratic senators, including a presidential candidate and another potential candidate, introduced a bill to let the government condition drug exclusivity on companies keeping price increases in the single digits. The approach is designed to be more aggressive than merely asking companies to justify prices, yet less aggressive than either the outright government price negotiation sought by many Democrats or the foreign reference pricing proposed by the administration, an originator of the idea said. The bill also seems aimed at...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.